Serpin Pharma receives FDA IND approval for SP16, a novel therapy for chemotherapy-induced peripheral neuropathy. Phase ...
Dogwood licensed SP16 to treat cancer-related pain from partner and regulatory sponsor Serpin Pharma The SP16 Phase 1b trial ...
A burning sensation in the feet at night may be more than simple fatigue—it could signal underlying nerve damage or peripheral neuropathy ...
A dietitian shares the vitamin E deficiency symptoms that could be hurting your quality of life. Plus, how to make sure ...
Dogwood licensed SP16 to treat cancer-related pain from partner and regulatory sponsor Serpin Pharma The SP16 Phase 1b trial fully funded by the National Cancer Institute; Patient enrollment expected ...
A mum who thought her symptoms were down to having a 'dodgy burger' and was reassured by her GP later thought the signs were ...
Townlands Memorial Hospital is set to get a new important diagnostic machine worth more than £20,000 – thanks to the ‘largest ...
Phase 1/2 RAINFOL™-01 data showed the combination ofrinatabart sesutecan (Rina-S®) and bevacizumab was tolerable, with no new safety signals in patients with advanced ovarian c ...
A Varanasi-based businessman was allegedly poisoned with thallium, a rare and highly toxic substance, prompting the police to register an attempt to murder case ...
Veterans who developed neurodegenerative conditions after deploying to Afghanistan and Iraq are being sought for a NASEM ...
Many people assume no harm can come from loading up on vitamins. Despite the boosts, however, experts speaking to the Daily ...
Everyday Health on MSN
First-line treatment options for advanced urothelial carcinoma
First-line treatment for advanced urothelial carcinoma has evolved in recent years from traditional chemotherapy to targeted immunotherapy drugs enfortumab vedotin (Padcev) and pembrolizumab (Keytruda ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results